| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-06-10 | NCT07640048 Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study | Recruiting | |
| 2026-06-02 | NCT07621484 HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06461910 | Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage… | Gastric Cancer | Recruiting |
| NCT06339619 | Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and… | Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma | Recruiting |
| NCT07374250 | Perioperative Ivonescimab Plus S-1 and Oxaliplatin (SOX) for Locally Advanced Gastric or… | Gastric Cancer | Not Yet Recruiting |
| NCT07384234 | SHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction… | Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma | Not Yet Recruiting |
| NCT06256328 | A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab… | Gastric Cancer | Active, Not Recruiting |
| NCT07515625 | Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable… | Gastric Cancer (GC) | Not Yet Recruiting |
| NCT07561775 | Adebrelimab Plus S-1 for Resected Cholangiocarcinoma | Cholangiocarcinoma | Not Yet Recruiting |
| NCT07621484 | HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer | Locally Advanced Gastric Cancer | Not Yet Recruiting |
| Phase 1 | |||
| NCT05867121 | A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With… | Non-small Cell Lung Cancer | Active, Not Recruiting |
| Not specified | |||
| NCT07640048 | Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study | Intrahepatic Cholangiocarcinoma (Icc) | Recruiting |